XML 50 R40.htm IDEA: XBRL DOCUMENT v3.20.2
RELATED PARTY TRANSACTIONS (Details) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 6 Months Ended
Jun. 28, 2019
Jul. 31, 2017
Mar. 31, 2017
Mar. 31, 2020
Sep. 30, 2019
Sep. 30, 2018
Jun. 27, 2019
Dec. 31, 2019
Related Party Transaction [Line Items]                
Fixed interest rate             10.16%  
Number Of Common Stock Need To Hold To Designate As Director   600,000            
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.01              
Warrant to purchase shares of common stock 10,000,000              
Class Of Warrants Or Rights, Expiry Period   5 years            
Royalty Receivable       $ 30       $ 82
AD Pharma Agreement                
Related Party Transaction [Line Items]                
Proceeds from License Fees Received $ 350              
Period until which monthly license payment is receivable 18 months              
MainPointe (Nexafed)                
Related Party Transaction [Line Items]                
Proceeds from License Fees Received     $ 2,500          
Asset Transferred, License Agreement     $ 309          
Licensing Agreement, Royalty Percentage     7.50%          
MainPointe (Nexafed) | Royalty [Member]                
Related Party Transaction [Line Items]                
Royalty revenues         $ 21 $ 24    
Investor [Member]                
Related Party Transaction [Line Items]                
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 0.528            
Warrant to purchase shares of common stock   1,782,531,000,000            
Investor [Member] | Private Placement [Member]                
Related Party Transaction [Line Items]                
Sale of Stock, Consideration Received on Transaction   $ 4,000            
Sale of Stock, Number of Shares Issued in Transaction   8,912,655            
Sale of Stock, Price Per Share   $ 0.4488            
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 0.528            
Sale Of Stock, Issue Price Description   85%            
Warrants Not Settleable in Cash, Fair Value Disclosure       495        
Proceeds from Issuance of Warrants       $ 4,000        
Warrant to purchase shares of common stock   1,782,532            
Schutte                
Related Party Transaction [Line Items]                
Aggregate principal of promissory notes and accrued interest $ 6,000              
Fixed interest rate 7.50%              
Share Price $ 0.16              
Debt Conversion, Converted Instrument, Warrants or Options Issued 10,000,000              
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.01              
Debt Conversion, Converted Instrument, Shares Issued 37,500,000              
Proceeds from Issuance of Long-term Debt $ 725           $ 650  
Schutte | AD Pharma Agreement                
Related Party Transaction [Line Items]                
Aggregate principal of promissory notes and accrued interest $ 6,000              
Debt Conversion, Converted Instrument, Warrants or Options Issued 10,000,000              
Abuse Deterrent Pharma, LLC                
Related Party Transaction [Line Items]                
Proceeds from License Fees Received $ 350              
Abuse Deterrent Pharma, LLC | AD Pharma Agreement                
Related Party Transaction [Line Items]                
Proceeds from License Fees Received $ 350              
Period until which monthly license payment is receivable 18 months     5 years